XML 40 R1.htm IDEA: XBRL DOCUMENT v3.20.1
COVER PAGE - USD ($)
12 Months Ended
Dec. 31, 2019
Mar. 16, 2020
Cover page.    
Entity Registrant Name SALARIUS PHARMACEUTICALS, INC.  
Entity Central Index Key 0001615219  
Current Fiscal Year End Date --12-31  
Document Annual Report true  
Document Transition Report false  
Entity Filer Category Non-accelerated Filer  
Document Type 10-K  
Document Period End Date Dec. 31, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus FY  
Amendment Flag false  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Shell Company false  
Title of 12(b) Security Common Stock, par value $ 0.0001  
Trading Symbol SLRX  
Security Exchange Name NASDAQ  
Entity File Number 001-36812  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 2450 Holcombe Blvd  
Entity Address, Address Line Two Suite J 608  
Entity Address, City or Town Houston  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 77021  
Entity Tax Identification Number 46-5087339  
City Area Code 346  
Local Phone Number 772-0346  
Entity Public Float   $ 9,203,679
Entity Common Stock, Shares Outstanding   13,666,453
Documents Incorporated by Reference Portions of the registrant’s definitive proxy statement for its 2020 Annual Meeting of Stockholders, which will be filed with the United States Securities and Exchange Commission within 120 days of December 31, 2019, are incorporated by reference into Part III of this Annual Report on Form 10-K.